First-in-human Trial of DS-2243a in Participants with Advanced Solid Tumors
DS2243-054
Phase 1 other active
Quick answer
First-in-human Trial of DS-2243a in Participants with Advanced Solid Tumors for Advanced Solid Tumor is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- other
- Status
- active